Lineage Cell Therapeutics
LCTX
LCTX
104 hedge funds and large institutions have $89.1M invested in Lineage Cell Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 9 closing their positions.
Holders
104
Holders Change
-3
Holders Change %
-2.8%
% of All Funds
1.66%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
26
Reduced
24
Closed
9
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
+$16K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$9.81M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$3.27M |
| 3 |
3
BlackRock
New York
|
$11M |
| 4 |
4
Morgan Stanley
New York
|
$328K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.42M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FWM
101
Focused Wealth Management
Newburgh,
New York
| $9 | – | – | – |
|
|
NFSG
102
Newbridge Financial Services Group
Boca Raton,
Florida
| $6 | – | – | – |
|
|
DJSG
103
D.J. St. Germain
Springfield,
Massachusetts
| $2 | – | – | – |
|
|
HF
104
HRT Financial
New York
| – | -$1.05M | -744,628 | Closed |
|
|
DCM
105
DAFNA Capital Management
Los Angeles,
California
| – | -$197K | -140,000 | Closed |
|
106
Two Sigma Investments
New York
| – | -$115K | -81,816 | Closed |
|
107
Verition Fund Management
Greenwich,
Connecticut
| – | -$59.6K | -42,304 | Closed |
|
108
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$58.1K | -41,181 | Closed |
|
|
GCP
109
GSA Capital Partners
London,
United Kingdom
| – | -$19K | -13,196 | Closed |
|
|
AIC
110
Archer Investment Corporation
Carmel,
Indiana
| – | -$1.41K | -1,000 | Closed |
|
111
Group One Trading
Chicago,
Illinois
| – | -$1.37K | -972 | Closed |
|
|
SCA
112
Stonebridge Capital Advisors
St Paul,
Minnesota
| – | -$41 | -29 | Closed |
|